This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Efficacy Study Comparing VELCADE DEXAMETHASONE THA...
Clinical trial

Efficacy Study Comparing VELCADE DEXAMETHASONE THALIDOMIDE Versus VELCADE CYCLOPHOSPHAMIDE DEXAMETHASONE as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

Read time: 1 mins
Last updated:30th Sep 2013
This is a phase III, multicenter, prospective with a clinical benefit, open-label and randomized study to compare two different treatments : Velcade (Bortezomib) Thalidomide Dexamethasone (VTD) versus Velcade (Bortezomib) Cyclophosphamide Dexamethasone (VCD) as an Induction Treatment prior to Autologous Stem Cell Transplantation in patients with Newly Diagnosed Multiple Myeloma.
Category Value
Study start date 2013-09-30

View full details